“ "This year, as we are still under the business consolidation process with Dolder, we expect to grow around 35 percent in 2016, but the potential ahead… ”
In Conversation
“ "Marzam has gone through a lot of changes in the last 10 years. We are a big company - 2,700 employees, which is down from 3,400… ”
“ "Our mix of revenues of pharmaceutical versus medical devices has varied throughout the last three years, hand in hand with the performance of each industry." ”
“ "Our culture has always fostered hard teamwork. We do not believe in magic formulas or special talents but attitude has been our main driver. Our positioning… ”
“ "Our biggest accomplishment during the last five years has been the consolidation of our manufacturing site thanks to the investments that we have recently carried out.… ”
“ "In the grand scheme of things, our overarching objective is to ensure our entire portfolio is accessible to Latin American patients in all countries of the… ”
Interview: María Eugenia Méndez – Healthcare & Life Science Leader; Jorge Romero Castañeda – Strategy & Operations Director, Deloitte Mexico
“ "The pharmaceutical industry in Mexico moved from growing at double digit to single digit pace and for many companies, the private industry has decreased its contribution… ”
“ "Shire’s fundamental mission is to support and change the lives of an increasing number of patients affected by rare diseases. In this regard, Mexico clearly emerges… ”
“ "Besides being the second largest market in Latin America, the Mexican health eco-system is unique in many ways, in areas like innovation access, distribution and the… ”
“ "We see our long-standing relationship with Mexico’s public sector as a true partnership between our company and IMSS, ISSSTE and other social security institutions of the… ”
“ "As a company, we work hand in hand with our customers, and we see ourselves more as an extension of their offices than as basic service… ”
“ "The existing gap between the prices of generics, brand-generics and drugs from the innovator brands is not sustainable in the mid-term. Prices must be balanced in… ”